A case of guttate psoriasis during treatment with dupilumab-Reference-Cited by-同舟云学术

A case of guttate psoriasis during treatment with dupilumab

Published:2019-06-30 Issue:5 Volume:32 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Gori Niccolò¹,Caldarola Giacomo¹,Pirro Federico¹,De Simone Clara¹^ORCID,Peris Ketty¹

Affiliation:

1. Institute of DermatologyCatholic University—Fondazione Policlinico Universitario A. Gemelli IRCCS Rome Italy

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.12998

Reference5 articles.

1. IL‐4 abrogates T(H)17 cell‐mediated inflammation by selective silencing of IL‐23 in antigen‐presenting cells;Guenova E.;Proceedings of the National Academy of Sciences of the United States of America,2015

2. Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment

3. Psoriasis induced by dupilumab therapy

4. Erythrodermic presentation of psoriasis in a patient treated with dupilumab

5. A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Guttate Psoriasis: A Systematic Review;Journal of Cutaneous Medicine and Surgery;2024-07-30

2. Childhood guttate psoriasis: an updated review;Drugs in Context;2023-10-23

3. Development of a clinical algorithm to predict phenotypic switches between atopic dermatitis and psoriasis (the “Flip‐Flop” phenomenon);Allergy;2023-10-21

4. “De Novo” Psoriasis and Relapse of Psoriasis Induced by Dupilumab: Three New Cases and Review of the Literature;Journal of Clinical Medicine;2023-09-29

5. Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective;Dermatology Reports;2023-09-13